Maria Ruzzene相关文献与解析，生知库 | 链接生命科学的每一步

Giorgia Di Lorenzo,Francescopaolo Iavarone,Marianna Maddaluno,Ana Belén Plata-Gómez,Simone Aureli,Camila Paz Quezada Meza,Laura Cinque,Alessandro Palma,Alessio Reggio,Carmine Cirillo,Francesca Sacco,Alexandra Stolz,Gennaro Napolitano,Oriano Marin,Lorenzo A Pinna,Maria Ruzzene,Vittorio Limongelli,Alejo Efeyan,Paolo Grumati,Carmine Settembre

自噬

磷酸化

发表日期：2022

文献求助收藏

Contribution of the CK2 Catalytic Isoforms α and α' to the Glycolytic Phenotype of Tumor Cells

CK2 催化异构体 α 和 α' 对肿瘤细胞糖酵解表型的贡献

期刊:Cells

影响因子:5.1

doi:10.3390/cells10010181

Francesca Zonta, Christian Borgo, Camila Paz Quezada Meza, Ionica Masgras, Andrea Rasola, Mauro Salvi, Lorenzo A Pinna, Maria Ruzzene

Effects of CK2β subunit down-regulation on Akt signalling in HK-2 renal cells

CK2β亚基下调对HK-2肾细胞Akt信号传导的影响

期刊:PLoS One

影响因子:2.9

doi:10.1371/journal.pone.0227340

Estefania Alcaraz, Jordi Vilardell, Christian Borgo, Eduard Sarró, Maria Plana, Oriano Marin, Lorenzo A Pinna, José R Bayascas, Anna Meseguer, Mauro Salvi, Emilio Itarte, Maria Ruzzene

The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells

蛋白激酶 CK2 促进胆管癌细胞的恶性表型

期刊:Oncogenesis

影响因子:5.9

doi:10.1038/s41389-019-0171-x

Giovanni Di Maira, Alessandra Gentilini, Mirella Pastore, Alessandra Caligiuri, Benedetta Piombanti, Chiara Raggi, Elisabetta Rovida, Monika Lewinska, Jesper B Andersen, Christian Borgo, Mauro Salvi, Daniele Ottaviani, Maria Ruzzene, Fabio Marra

Under-expression of CK2β subunit in ccRCC represents a complementary biomarker of p-STAT3 Ser727 that correlates with patient survival

ccRCC 中 CK2β 亚基的低表达代表 p-STAT3 Ser727 的互补生物标志物，与患者生存相关

期刊:Oncotarget

影响因子:

doi:10.18632/oncotarget.23422

Jordi Vilardell, Estefania Alcaraz, Eduard Sarró, Enric Trilla, Thaïs Cuadros, Inés de Torres, Maria Plana, Santiago Ramón Y Cajal, Lorenzo A Pinna, Maria Ruzzene, Juan Morote, Anna Meseguer, Emilio Itarte

信号转导

发表日期：2017

文献求助收藏

Targeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice

靶向蛋白激酶 CK2：评估 CX-4945 对免疫功能正常小鼠的 GL261 胶质母细胞瘤治疗潜力

期刊:Pharmaceuticals

影响因子:

doi:10.3390/ph10010024

Laura Ferrer-Font, Lucia Villamañan, Nuria Arias-Ramos, Jordi Vilardell, Maria Plana, Maria Ruzzene, Lorenzo A Pinna, Emilio Itarte, Carles Arús, Ana Paula Candiota

Differential phosphorylation of Akt1 and Akt2 by protein kinase CK2 may account for isoform specific functions

蛋白激酶 CK2 对 Akt1 和 Akt2 的差异磷酸化可能解释同工型特异性功能

期刊:

影响因子:3.3

doi:10.1016/j.bbamcr.2014.04.020

Cristina Girardi, Peter James, Sofia Zanin, Lorenzo A Pinna, Maria Ruzzene

Synthesis and properties of a selective inhibitor of homeodomain-interacting protein kinase 2 (HIPK2)

同源域相互作用蛋白激酶 2 (HIPK2) 选择性抑制剂的合成及特性

期刊:PLoS One

影响因子:2.9

doi:10.1371/journal.pone.0089176

Giorgio Cozza, Sofia Zanin, Renate Determann, Maria Ruzzene, Conrad Kunick, Lorenzo A Pinna

信号转导

发表日期：2014

文献求助收藏

Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity

使用临床级小分子 ATP 竞争性化合物 CX-4945 或 RNA 干扰抑制蛋白激酶 CK2，揭示其在急性髓系白血病细胞存活、p53 依赖性细胞凋亡和柔红霉素诱导的细胞毒性中的作用

期刊:Journal of Hematology & Oncology

影响因子:29.5

doi:10.1186/1756-8722-6-78

Laura Quotti Tubi, Carmela Gurrieri, Alessandra Brancalion, Laura Bonaldi, Roberta Bertorelle, Sabrina Manni, Laura Pavan, Federica Lessi, Renato Zambello, Livio Trentin, Fausto Adami, Maria Ruzzene, Lorenzo A Pinna, Gianpietro Semenzato, Francesco Piazza

Aberrant signalling by protein kinase CK2 in imatinib-resistant chronic myeloid leukaemia cells: biochemical evidence and therapeutic perspectives

伊马替尼耐药慢性粒细胞白血病细胞中蛋白激酶 CK2 的异常信号传导：生化证据和治疗前景

期刊:Molecular Oncology

影响因子:5

doi:10.1016/j.molonc.2013.08.006

Christian Borgo, Luca Cesaro, Valentina Salizzato, Maria Ruzzene, Maria Lina Massimino, Lorenzo A Pinna, Arianna Donella-Deana

Phosphorylation of FAM134C by CK2 controls starvation-induced ER-phagy

CK2 对 FAM134C 的磷酸化控制饥饿诱导的内质网自噬

Contribution of the CK2 Catalytic Isoforms α and α' to the Glycolytic Phenotype of Tumor Cells

CK2 催化异构体 α 和 α' 对肿瘤细胞糖酵解表型的贡献

Effects of CK2β subunit down-regulation on Akt signalling in HK-2 renal cells

CK2β亚基下调对HK-2肾细胞Akt信号传导的影响

The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells

蛋白激酶 CK2 促进胆管癌细胞的恶性表型

Under-expression of CK2β subunit in ccRCC represents a complementary biomarker of p-STAT3 Ser727 that correlates with patient survival

ccRCC 中 CK2β 亚基的低表达代表 p-STAT3 Ser727 的互补生物标志物，与患者生存相关

Targeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice

靶向蛋白激酶 CK2：评估 CX-4945 对免疫功能正常小鼠的 GL261 胶质母细胞瘤治疗潜力

Differential phosphorylation of Akt1 and Akt2 by protein kinase CK2 may account for isoform specific functions

蛋白激酶 CK2 对 Akt1 和 Akt2 的差异磷酸化可能解释同工型特异性功能

Synthesis and properties of a selective inhibitor of homeodomain-interacting protein kinase 2 (HIPK2)

同源域相互作用蛋白激酶 2 (HIPK2) 选择性抑制剂的合成及特性

Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity

使用临床级小分子 ATP 竞争性化合物 CX-4945 或 RNA 干扰抑制蛋白激酶 CK2，揭示其在急性髓系白血病细胞存活、p53 依赖性细胞凋亡和柔红霉素诱导的细胞毒性中的作用

Aberrant signalling by protein kinase CK2 in imatinib-resistant chronic myeloid leukaemia cells: biochemical evidence and therapeutic perspectives

伊马替尼耐药慢性粒细胞白血病细胞中蛋白激酶 CK2 的异常信号传导：生化证据和治疗前景